Clinical Trial Results:
            Preoperative combined RadioChemo-MolecularTargetedTherapie (RC-MTTx) of the locally advanced rectal carcinoma (cT3NxM0) – a phase II pilot study with preoperative application of capecitabine (Xeloda), bevacizumab (Avastin) and radiotherapy (RTx)
    
|     Summary | |
|     EudraCT number | 2007-006750-26 | 
|     Trial protocol | AT | 
|     Global completion date | |
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | |
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    24 Jun 2021
                             | 
|     First version publication date | 
                                    24 Jun 2021
                             | 
|     Other versions | |
|     Summary report(s) | Summary Report ABCSG R04 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
